Genome of emerging antibiotic resistant bacteria decoded

An analysis of the largest genetically decoded collection of the bacterial pathogen Klebsiella pneumoniae, which causes a spectrum of diseases in humans and animals, reveals the impact of antibiotic treatment on its population structure and provides the tools needed to track this important pathogen.

 

While not well known to the public, Klebsiella pneumoniae has recently been highlighted by the UK Chief Medical Officer, the European Centre for Disease Prevention and Control and the World Health Organization as an urgent and immediate threat to health.

K. pneumoniae can cause a wide range of acute infections such as meningitis and pneumonia. In lower-income countries, the bacteria are one of the most common causes of bloodstream infections in infants and a leading cause of premature deaths. It is hoped that this data set, comprised of whole genome sequences of nearly 300 plant, bovine and human samples from around the world, will increase understanding of the bacterium and help scientists to track rapidly evolving antibiotic resistance across different species and lineages.

“For too long with Klebsiella, we have focussed on single lineages,” says Professor Nick Thomson, corresponding author from the Wellcome Trust Sanger Institute. “We will now be able to recognise emerging lineages from a huge cloud of Klebsiella diversity, helping us to follow and tackle drug resistance in this increasingly dangerous pathogen.”

Researchers found that the distribution of genes responsible for conferring drug resistance varied according to the geographical origin of the sample, not according to the specific strain of K. pneumoniae. This shows that evolution of the pathogen is directly linked to local antibiotic use and that these resistance elements regularly transfer between different strains.

Most drug-resistance genes were discovered in samples from patients with infections they acquired while receiving treatment for another illness in hospital, or from people who carried the bacteria without showing any symptoms of infection. These strains are generally less infectious and unlikely to affect a healthy individual. However, researchers are concerned, given the ease with which different strains of the bacteria can share genetic information, that antibiotic resistance genes may soon appear in more virulent Klebsiella strains, creating an untreatable and highly infectious bacterial population.

“Almost any Klebsiella pneumoniae can cause an infection in someone who is already ill in hospital, but very few strains are virulent enough to affect a healthy person,” explains Dr Kathryn Holt, first author from The University of Melbourne. “So far we have been extremely lucky in that most of the antibiotic-resistant strains are not highly virulent to humans. Unfortunately, Klebsiella strains are very good at swapping around genes that encode antibiotic resistance, so it’s probably just a matter of time before we see strains that have the dreaded combination of virulence and antibiotic resistance.”

Currently, antibiotic resistance genes are monitored in hospital laboratories; this research demonstrates the importance of also tracking the genes that determine how virulent a strain is. In this study, researchers found that many of the strains of K. pneumoniae that were virulent enough to cause serious infections in people who weren’t already ill in hospital, contain genes that help them to steal iron away from human cells. Iron is essential for bacteria to replicate, so these organisms are better able to compete for iron and replicate more easily during a human infection, where iron is scarce. This feature makes them more able to infect healthy hosts and, when tested for, could help researchers to identify and track hypervirulent strains.

The study also provides a foundation for further studies into how these bacteria adapt to new niches and how they become more diverse. Active surveillance for virulence genes and antibiotic resistance will also be crucial as the prevalence of this pathogen continues to rise.

“In Asia, K. pneumoniae infections are becoming increasingly common and increasingly associated with mortality,” says Professor Stephen Baker, an author from the Oxford University Clinical Research Unit in Vietnam. “If the trends we are seeing here in Vietnam and across Asia continue, drug-resistant Klebsiella will become an even more predominant and an exceptionally dangerous pathogen.”



Publication details

Holt KE, et al. (2015). Diversity, population structure, virulence and antimicrobial resistance of Klebsiella pneumoniae, an urgent threat to public health. Proceedings of the National Academy of Sciences.

DOI: 10.1073/pnas.1501049112.

Funding

This work was funded by: the NHMRC of Australia, fellowship #628930 and #1061409, program grant #606788; the Wellcome Trust, grant #098051 to Wellcome Trust Sanger Institute, grant #089275/H/09/Z for the Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Sir Henry Dale Fellowship (co-funded by the Royal Society); the Victorian Life Science Computation Initiative grant #VR0082.  

*******

Contact details

Don Powell      Media Manager
Wellcome Trust Sanger Institute
Hinxton, Cambridge, CB10 1SA, UK
Tel        +44 (0)1223 496 928
Mobile  +44 (0)7753 7753 97
Email    press.office@sanger.ac.uk

___________________________________________________



Read more

Looking for something specific?